Zobrazeno 1 - 10
of 39
pro vyhledávání: '"Wayne B Harris"'
Autor:
Dylan J. Martini, T. Anders Olsen, Subir Goyal, Yuan Liu, Sean T. Evans, Emilie Elise Hitron, Greta Anne Russler, Lauren Yantorni, Sarah Caulfield, Jacqueline T. Brown, Jamie M. Goldman, Bassel Nazha, Bradley C. Carthon, Wayne B. Harris, Omer Kucuk, Viraj A Master, Mehmet Asim Bilen
Publikováno v:
Journal of Immunotherapy and Precision Oncology, Pp 52-57 (2022)
Introduction: There are three combination immune checkpoint inhibitor (ICI)–based regimens in the first-line setting for metastatic renal cell carcinoma (mRCC). Currently, there is limited real-world data for clinical outcomes and toxicity in mRCC
Externí odkaz:
https://doaj.org/article/3b523ccfbd2e4ae9ba07ac843f39a4e8
Autor:
Julie M. Shabto, Dylan J. Martini, Yuan Liu, Deepak Ravindranathan, Jacqueline Brown, Emilie E. Hitron, Greta A. Russler, Sarah Caulfield, Haydn Kissick, Mehrdad Alemozaffar, Kenneth Ogan, Wayne B. Harris, Viraj A. Master, Omer Kucuk, Bradley C. Carthon, Mehmet A. Bilen
Publikováno v:
Cancer Medicine, Vol 9, Iss 8, Pp 2752-2760 (2020)
Abstract Background We developed a novel risk scoring system for urothelial cancer (UC) patients receiving immune checkpoint inhibitors (ICI). Methods We conducted a retrospective review of 67 UC patients treated with ICI at Winship Cancer Institute
Externí odkaz:
https://doaj.org/article/c4c3b05ccaa44df48e328161b5208ced
Autor:
Dylan J. Martini, T. Anders Olsen, Subir Goyal, Yuan Liu, Sean T. Evans, Benjamin Magod, Jacqueline T. Brown, Lauren Yantorni, Greta Anne Russler, Sarah Caulfield, Jamie M. Goldman, Bassel Nazha, Haydn T. Kissick, Wayne B. Harris, Omer Kucuk, Bradley C. Carthon, Viraj A. Master, Mehmet Asim Bilen
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
BackgroundImmune checkpoint inhibitors (ICI) have revolutionized the treatment of metastatic renal cell carcinoma (mRCC). Biomarkers for mRCC patients treated with ICI are limited, and body composition is underutilized in mRCC. We investigated the as
Externí odkaz:
https://doaj.org/article/9162907753ca46b98f276622972a2ce3
Autor:
Yuan Liu, Haydn Kissick, Viraj A Master, Mehmet Asim Bilen, Dylan Martini, Lauren Yantorni, Sarah Caulfield, Bassel Nazha, Omer Kucuk, Deepak Ravindranathan, Kenneth Ogan, Jacqueline T Brown, Julie M Shabto, Emilie Elise Hitron, Greta Anne Russler, Shreyas Subhash Joshi, Bradley C Carthon, Wayne B Harris
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 7 (2021)
Background The modified Glasgow Prognostic Score (mGPS) is a composite biomarker that uses albumin and C reactive protein (CRP). There are multiple immune checkpoint inhibitor (ICI)-based combinations approved for metastatic renal cell carcinoma (mRC
Externí odkaz:
https://doaj.org/article/4f2dc748bda445bcbb2fb153c0efb1a8
Autor:
T. Anders Olsen, Dylan J. Martini, Subir Goyal, Yuan Liu, Sean T. Evans, Benjamin Magod, Jacqueline T. Brown, Lauren Yantorni, Greta Anne Russler, Sarah Caulfield, Jamie M. Goldman, Wayne B. Harris, Omer Kucuk, Bradley C. Carthon, Viraj A. Master, Bassel Nazha, Mehmet Asim Bilen
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
BackgroundImmune-checkpoint-inhibitors (ICIs) have become the cornerstone of metastatic renal-cell-carcinoma (mRCC) therapy. However, data are limited regarding clinical outcomes by race. In this study, we compared the real-world outcomes between Afr
Externí odkaz:
https://doaj.org/article/3aa9b41eb0064fb78cd9cab2b089a0c5
Autor:
Dylan J. Martini, Meredith R. Kline, Yuan Liu, Julie M. Shabto, Bradley C. Carthon, Greta Anne Russler, Lauren Yantorni, Emilie Elise Hitron, Sarah Caulfield, Jamie M. Goldman, Wayne B. Harris, Omer Kucuk, Viraj A Master, Mehmet Asim Bilen
Publikováno v:
Cancer Treatment and Research Communications, Vol 28, Iss , Pp 100393- (2021)
Background: Cabozantinib is an effective treatment for metastatic renal cell carcinoma (mRCC). The international mRCC database consortium (IMDC) criteria is the gold standard for risk stratification in mRCC. We created a risk scoring system specific
Externí odkaz:
https://doaj.org/article/88cfc89656924a159ed5e19c6f52d91b
Autor:
Rishi R. Sekar, Dattatraya Patil, Yoram Baum, Jeffrey Pearl, Anna Bausum, Mehmet A. Bilen, Omer Kucuk, Wayne B. Harris, Bradley C. Carthon, Mehrdad Alemozaffar, Christopher P. Filson, John G. Pattaras, Peter T. Nieh, Kenneth Ogan, Viraj A. Master
Publikováno v:
Asian Journal of Urology, Vol 4, Iss 4, Pp 230-238 (2017)
Objective: Several inflammatory markers have been studied as potential biomarkers in renal cell carcinoma (RCC), however few reports have analyzed their prognostic value in aggregate and in non-clear cell histologies. We hypothesize that a combinatio
Externí odkaz:
https://doaj.org/article/c52e52aa4f834a8889b9e302f85ca1c4
Autor:
Wayne B Harris, Chao Zhang, Yuan Liu, Dale K Robertson, Mikhail Y Akbashev, Brian M Lingerfelt, Omer Kucuk, Bradley C Carthon, Theresa W Gillespie, Adeboye O Osunkoya, Viraj A Master
Publikováno v:
Tumor Biology, Vol 39 (2017)
The goal of this study was to examine time-dependent effects of prognostic biomarkers of systemic inflammation in patients with metastatic renal cell carcinoma. Retrospective chart reviews were conducted at the Winship Cancer Institute of Emory Unive
Externí odkaz:
https://doaj.org/article/604558ee9cd14030b15ff74d5024d914
Autor:
Caroline G Tai, Timothy V Johnson, Ammara Abbasi, Lindsey Herrell, Wayne B Harris, Omer Kucuk, Daniel J Canter, Kenneth Ogan, John G Pattaras, Peter T Nieh, Viraj A Master
Publikováno v:
Indian Journal of Urology, Vol 30, Iss 1, Pp 33-37 (2014)
Purpose: The modified Glasgow prognostic Score (mGPS) incorporates C-reactive protein and albumin as a clinically useful marker of tumor behavior. The ability of the mGPS to predict metastasis in localized renal cell carcinoma (RCC) remains unknown i
Externí odkaz:
https://doaj.org/article/8d4114a27e7445acb72d08ef57ead841
Autor:
Brian W. Cross, Timothy V. Johnson, Austin B. DeRosa, Kenneth Ogan, John G. Pattaras, Peter T. Nieh, Omer Kucuk, Wayne B. Harris, Viraj A. Master
Publikováno v:
International Journal of Surgical Oncology, Vol 2012 (2012)
Objectives. To determine the relationship between preoperative erythrocyte sedimentation rate (ESR) and overall survival in localized renal cell carcinoma (RCC) following nephrectomy. Methods. 167 patients undergoing nephrectomy for localized RCC had
Externí odkaz:
https://doaj.org/article/444e66ea7062419d94629002679100dd